Skip to main content
SpringerLink
Log in

Intrathecal Drug Delivery by Implanted Pumps

  • Protocol
  • First Online:
Drug Delivery to the Central Nervous System

Part of the book series: Neuromethods ((NM,volume 45))

Abstract

Direct central neural axis neuromodulation has become a viable means to treat chronic neurologic disease and injury. Although first described in 1898, technology has only recently allowed for strict modulation and adjustments of drug delivery into the centeral nervous system. Evolving congruently with understanding of the altered neurophysiology and an expanding pharmacologic armamentarium, intrathecal pump systems augment treatment in an ever expanding number of disorders. In this review, we present a general historical overview of direct neuroaxis delivery and discuss current indications for intrathecal delivery with considerations in patient and drug selection. Complications, both surgical and medical, are discussed in detail with focus on avoidance and management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Belverud S, Mogilner A, and Schulder M. Intrathecal therapies. Neurotherapeutics Jan 2008;5(1):114–122.

    Google Scholar 

  2. Patel MM, Goyal BR, Bhadada SV, Bhatt JS et al. Getting into the brain: approaches to enhance brain drug delivery. CNS Drugs 2009;23(1):35–58.

    Article  CAS  PubMed  Google Scholar 

  3. Hazard RG, Haugh LD, Green PA et al. Chronic low back pain: the relationship between patient satisfaction and pain, impairment and disability outcomes. Spine 1994;19:81–87.

    Google Scholar 

  4. Arnstein P, Caudill M, Mandle CL et al. Self efficacy as a mediator of the relationship between pain intensity, disability and depression in chronic pain patients. Pain 1999;80:483–491.

    Article  CAS  PubMed  Google Scholar 

  5. Schmitz U, Saile H, and Nilges P. Coping with chronic pain: flexible goal adjustment as an interactive buffer against pain-related distress. Pain 1996;67:41–51.

    Article  CAS  PubMed  Google Scholar 

  6. Zhang X and Bao L. The development and modulation of nociceptive circuitry. Curr Opin Neruobiol 2006 Aug;16(4):460–466.

    Google Scholar 

  7. Pereira J, Lawlor P, Vigano A et al. Equianalgesic dose ratios for opioids. A critical review and proposals for long-term dosing. J Pain Symptom Manage 2001 Aug;22(2):672–687.

    Google Scholar 

  8. Lindsay SM. The conversion challenge: from intrathecal to oral morphine. Am J Hosp Palliat Care 2004;21:143–147.

    Article  PubMed  Google Scholar 

  9. Brill S, Gurman GM, and Fisher A. A history of neuraxial administrationof local analgesics and opioids. Eur J Anaesthesiol 2003;20:682–689.

    Article  CAS  PubMed  Google Scholar 

  10. Pert CB and Snyder S. Opiate receptor: demonstration in nervous tissue. Science 1973;179(77):1011–1014.

    Article  CAS  PubMed  Google Scholar 

  11. Terenius L. Characteristics of the “receptor” for narcotic analgesics in synaptic plasma membrane fractions from rat brain. Acta Pharmacol Toxicol (Copenh) 1973;33(5):377–384.

    Article  CAS  Google Scholar 

  12. Yaksh TL and Rudy TA. Studies on the direct spinal action of narcotics in the production of analgesia in the rat. J Pharmacol Exp Ther 1977;202(2):411–428.

    CAS  PubMed  Google Scholar 

  13. Wang JK, Nauss LA, and Thomas JE. Pain relief by intrathecally applied morphine in man. Anesthesiology 1979;50(2):149–151.

    Article  CAS  PubMed  Google Scholar 

  14. Rico RC, Hobika GH, Avellanosa AM, Trudnowski RJ, Rempel J, and West CR. Use of intrathecal and epidural morphine for pain relief in patients with malignant diseases: a preliminary report. J Med 1982;13:223–231.

    CAS  PubMed  Google Scholar 

  15. Leavens ME, Hill CS, Jr, Cech DA, Weyland JB, and Weston JS. Intrathecal and intraventricular morphine for pain in cancer patients: initial study. J Neurosurg 1982;56:241–245.

    Article  CAS  PubMed  Google Scholar 

  16. Foley KM. Treatment of cancer pain. N Engl J Med 1985;313(2):84–95.

    Article  CAS  PubMed  Google Scholar 

  17. Brogan SE. Intrathecal therapy for the management of cancer pain. Curr Pain Headache Rep 2006;10:254–259.

    Article  PubMed  Google Scholar 

  18. Auld AW, Maki-Jokela A, and Murdoch DM. Intraspinal narcotic analgesia in the treatment of chronic pain. Spine 1985;10:777–781.

    Article  CAS  PubMed  Google Scholar 

  19. Krames ES. Intrathecal infusional therapies for intractable pain: patient management guidelines. J Pain Symptom Manage 1993;8(1):36–46.

    Article  CAS  PubMed  Google Scholar 

  20. Kanoff RB. Intraspinal delivery of opiates by an implantable, programmable pump in patients with chronic, intractable pain of nonmalignant origin. J Am Osteopath Assoc 1994;94(6):487–493.

    CAS  PubMed  Google Scholar 

  21. Hassenbusch SJ, Stanton-Hicks M, Covington EC et al. Long-term intraspinal infusions of opiods in the treatment of neuropathic pain. J Pain Symptom Manage 1995;10(7):527–543.

    Article  CAS  PubMed  Google Scholar 

  22. Winkelmuller M and Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996;85(3):458–467.

    Article  CAS  PubMed  Google Scholar 

  23. Paice JA, Penn RD, and Shott S. Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage 1996;11:71–80.

    Article  CAS  PubMed  Google Scholar 

  24. Nitescu P, Dahm P, Appelgren L, and Curelaru I. Continuous infusion of opioid and bupivacaine by externalized intrathecal catheters in long-term treatment of “refractory” nonmalignant pain. Clin J Pain 1998;14:17–28.

    Article  CAS  PubMed  Google Scholar 

  25. Staats PS, Yearwood T, Charapata SG et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized trial. J Am Med Assoc 2004 Jan 7;291(1):63–70.

    Google Scholar 

  26. Jain KK. An evaluation of intrathecal ziconotide for the treatment of chronic pain. Expert Opin Invastig Drugs 2000 Oct;9(10):2403–2410.

    Google Scholar 

  27. Webster LR, Fisher R, Charapata S, and Wallace MS. Long-term intrathecal ziconotide for chronic pain: an open label study. J Pain Symptom Manage 2008; Aug 19.

    Google Scholar 

  28. Kaplan KM and Brose WG. Intrathecal methods. Neurosurg Clin N Am 2004;15:289–296.

    Article  PubMed  Google Scholar 

  29. Meuser T, Pietruck C, Radbruch L et al. Symptoms during cancer pain treatment following WHO guidelines: a longitudinal follow-up study of symptoms prevalence, severity, and etiology. Pain 2001;93:247–257.

    Article  CAS  PubMed  Google Scholar 

  30. Penn RD. Neuraxial analgesic administration. In: Neurosurgical pain manage. Elsevier Saunders, Philadelphia, PA, 2004, 150–155.

    Chapter  Google Scholar 

  31. Follett KA and Doleys DM. Selection or candidates for intrathecal drug administration to treat chronic pain: considerations in pre-implantation trials. Medronic, Inc., Minneapolis, MN, 2002.

    Google Scholar 

  32. Hassenbusch SJ, Paice JA, Patt RB et al. Clinical realities and economic considerations: economics of intrathecal therapy. J Pain Symptom Manage 1997;14(3 Suppl):S36–S48.

    Article  CAS  PubMed  Google Scholar 

  33. France JC, Jorgenson SS, Lowe TG, and Dwyer AP. The use or intrathecal morphine for analgesia after posterolateral lumbar fusion: a prospective, double-blind, randomized study. Spine 1997;22:2272–2277.

    Article  CAS  PubMed  Google Scholar 

  34. Penn RD and Paice JA. Chronic intrathecal morphine for intractable pain. J Neurosurg 1997;67:182–186.

    Google Scholar 

  35. Jacobson L, Chabal C, and Brody MC. A dose – response study of intrathecal morphine: efficacy, duration, optimal dose and side-effects. Anesth Analg 1988;67:1082–1088.

    CAS  PubMed  Google Scholar 

  36. Uppal GS, Haider TT, Dwyer A, and Uppal JA. Reversible urinary retention secondary to excessive morphine delivered by an intrathecal morphine pump. Spine 1994;19:719–720.

    Article  CAS  PubMed  Google Scholar 

  37. Anderson VC, Cooke B, and Burchiel KJ. Intrathecal hydromorphone for chronic nonmalignant pain: a retrospective study. Pain Med 2001;2:287–297.

    Article  CAS  PubMed  Google Scholar 

  38. Abs R, Verhelst J, Maeyaert J et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000;85:2215–2222.

    Article  CAS  PubMed  Google Scholar 

  39. Aldrete JA and Couto da Silva JM. Leg edema from intrathecal opiate infusions. Eur J Pain 2000;4:361–365.

    Article  CAS  PubMed  Google Scholar 

  40. Hassenbusch SJ, Portenoy RK, Cousins M et al. Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery – report of an expert panel. J Pain Symptom Manage 2004;27:540–563.

    Article  PubMed  Google Scholar 

  41. Zieglgänsberger W, Howe JF, and Sutor B. The neuropharmacology of baclofen. In: Müller H, Zierski J, Penn RD, editors. Local-spinal therapy of spasticity. Springer-Verlag, Berlin, 1988, 37–49.

    Google Scholar 

  42. Penn RD and Kroin JS. Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1984;1(8385):1078.

    Article  CAS  PubMed  Google Scholar 

  43. Penn RD, Savoy SM, Corcos D et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989;320:1517–1521.

    Article  CAS  PubMed  Google Scholar 

  44. Müller H. Treatment of severe spasticity: results of multi-center trial conducted in Germany involving the intrathecal infusion of by an implantable drug delivery system. Dev Med Child Neurol 1992;34:739–745.

    Google Scholar 

  45. Albright AL, Cervi A, and Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. J Am Med Assoc 1991;265(11):1418–1422.

    Article  CAS  Google Scholar 

  46. van Hilten BJ, van de Beek WT, Hoff JI et al. Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy. N Engl J Med 2000;343(9):625–630.

    Article  PubMed  Google Scholar 

  47. Taricco M, Adone R, Pagliacci C et al. Pharmacological interventions for spasticity following spinal cord injury. Cochrane Database Syst Rev 2000;2:CD00131.

    Google Scholar 

  48. Herman RM, D’Luzansky JC, and Ippolito R. Intrathecal baclofen suppresses central pain in patients with spinal lesions. Clin J Pain 1992;8(4):338–345.

    Article  CAS  PubMed  Google Scholar 

  49. Loubser PG and Akman NM. Effects of intrathecal baclofen on chronic spinal cord injury pain. J Pain Symptom Manage 1996;12(4):241–247.

    Article  CAS  PubMed  Google Scholar 

  50. Young RR and Delwaide PJ. Drug therapy: spasticity (second of two parts). N Engl J Med 1981;304:96–99.

    Article  CAS  PubMed  Google Scholar 

  51. de Lissovoy G, Matza LS, Green H, Werner M, and Edgar T. Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy. J Child Neurol 2007 Jan;22(1):49–59.

    Google Scholar 

  52. Coffey RJ, Cahill D, Steers W et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993;78:226–232.

    Article  CAS  PubMed  Google Scholar 

  53. Penn RD. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 1992 Aug;77(2):236–240.

    Google Scholar 

  54. Taricco M, Adone R, Pagliacci C, and Telaro E. Pharmacological interventions for spasticity following spinal cord injury. Cochrane Database Syst Rev 2000;2:CD001131.

    Google Scholar 

  55. Armstrong RW, Steinbok P, Cochrane DD et al. Intrathecally administered baclofen for the treatment of children with spasticity of cerebral origin. J Neurosurg 1997;87:409–414.

    Article  CAS  PubMed  Google Scholar 

  56. Ivanhoe CB, Francisco GE, McGuire JR et al. Intrathecal baclofen management of poststroke spastic hypertonia: implications for function and quality of life. Arch Phys Med Rehabil 2006;87:1509–1515.

    Article  PubMed  Google Scholar 

  57. Ben Smail D, Peskine A, Roche N et al. Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients. Mult Scler 2006;12:101–103.

    Article  CAS  PubMed  Google Scholar 

  58. Francisco GE, Hu MM, Boake C, and Ivanhoe CB. Efficacy of early use of intrathecal baclofen therapy for treating spastic hypertonia due to acquired brain injury. Brain Inj 2005 May;19(5):359–364.

    Google Scholar 

  59. Albright AL, Barry MJ, Shafton DH, and Ferson SS. Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 2001;43:652–657.

    Article  CAS  PubMed  Google Scholar 

  60. Albright AL. Neurosurgical treatment of spasticity and other pediatric movement disorders. J Child Neurol 2003;18 (Suppl 1):S67–S78.

    PubMed  Google Scholar 

  61. D‘Aleo G, Rifici C, Kofler M et al. Favorable response to intrathecal, but not oral, baclofen of priapism in a patient with spinal cord injury. Spine 2009 Feb 1;34(3):E127-E129.

    Google Scholar 

  62. Cuny E, Richer E, and Castel JP. Dysautonomia syndrome in the acute recovery phase after traumatic brain injury: relief with intrathecal baclofen therapy. Brain Inj 2001 Oct;15(10):917–925.

    Google Scholar 

  63. Muller H, Zierski J, Dralle D et al. Pharmacokinetics of intrathecal baclofen. In: Muller H, Zierski J, Penn RD, editors. Local-spinal therapy of spasticity. Springer-Verlag, Berlin, 1988, 155–214.

    Google Scholar 

  64. Kofler M, Kronenberg MF, Rifici C et al. Epileptic seizures associated with intrathecal baclofen application. Neurology 1994;44:25–27.

    CAS  PubMed  Google Scholar 

  65. Buonaguro V, Scelsa B, Curci D et al . S. Epilepsy and intrathecal baclofen therapy in children with cerebral palsy. Pediatr Neurol 2005;33:110–113.

    Article  PubMed  Google Scholar 

  66. Jones ML, Leslie DP, Bilsky G, and Bowman B. Effects of intrathecal baclofen on perceived sexual functioning in men with spinal cord injury. J Spinal Cord Med 2008;31(1):97–102.

    PubMed  Google Scholar 

  67. Senaran H, Shah SA, Presedo A et al. The risk of progression of scoliosis in cerebral palsy patients after intrathecal baclofen therapy. Spine 2007 Oct 1;32(21):2348–2354.

    Google Scholar 

  68. Shilt JS, Lai LP, Cabrera MN et al. The impact of intrathecal baclofen on the natural history of scoliosis in cerebral palsy. J Pediatr Orthop 2008 Sep;28(6):684–687.

    Google Scholar 

  69. Kopell BH, Sala D, Doyle WK et al. Subfascial implantation of intrathecal baclofen pumps in children: technical note. Neurosurgery 2001;49:753–756.

    Article  CAS  PubMed  Google Scholar 

  70. Albright AL, Turner M, and Pattisapu JV. Best-practice surgical techniques for intrathecal baclofen therapy. J Neurosurg 2006;104:233–239.

    Article  PubMed  Google Scholar 

  71. McCall TD and MacDonald JD. Cervical catheter tip placement for intrathecal baclofen administration. Neurosurgery 2006;59:634–640.

    Article  PubMed  Google Scholar 

  72. Dickerman RD and Schneider SJ. Recurrent intrathecal baclofen pump catheter leakage: A surgical observation with recommendations. J Pediatr Surg 2002 Jun;37(6):E17.

    Google Scholar 

  73. Dickerman RD, Stevens QE, and Schneider SJ. The role of surgical placement and pump orientation in intrathecal pump system failure: A technical report. Pediatr Neurosurg 2003 Feb;38(2):107–109.

    Google Scholar 

  74. Huntoon MA, Hurdle MF, Marsh RW, and Reeves RK. Intrinsic spinal cord catheter placement: implications of new intractable pain in a patient with a spinal cord injury. Anesth Analg 2004;99:1763–1765.

    Article  PubMed  Google Scholar 

  75. Atiyeh BS, Hayek SN, Skaf GS, Al Araj A, and Chamoun RB. Baclofen pump pocket infection: a case report of successful salvage with muscle flap. Int Wound J 2006;3:23–28.

    Article  PubMed  Google Scholar 

  76. Boviatsis EJ, Kouyialis AT, Boutsikakis I et al. Infected CNS infusion pumps. Is there a chance for treatment without removal? Acta Neurochir (Wien) 2004;146:463–467.

    Article  CAS  Google Scholar 

  77. Shirley KW, Kothare S, Piatt JH, Jr, and Adirim TA. Intrathecal baclofen overdose and withdrawal. Pediatr Emerg Care 2006;22:258–261.

    Article  PubMed  Google Scholar 

  78. Greenberg MI and Hendrickson RG. Baclofen withdrawal following removal of an intrathecal baclofen pump despite oral baclofen replacement. J Toxicol Clin Toxicol 2003;41:83–85.

    Article  PubMed  Google Scholar 

  79. Wadhwa RK, Shaya MR, and Nanda A. Spinal cord compression in a patient with a pain pump for failed back syndrome: a chalk-like precipitate mimicking a spinal cord neoplasm: case report. Neurosurgery 2006;58:E387.

    Article  PubMed  Google Scholar 

  80. Bejjani GK, Karim NO, and Tzortzidis F. Intrathecal granuloma after implantation of a morphine pump: case report and review of the literature. Surg Neurol 1997;48:288–291.

    Article  CAS  PubMed  Google Scholar 

  81. Lew SM, Psaty EL, and Abbott R. An unusual cause of overdose after baclofen pump implantation: case report. Neurosurgery 2005;56:E624.

    Article  PubMed  Google Scholar 

  82. Lazorthes Y, Verdié JC, Bastide R et al. Spinal versus intraventricular chronic opiate administration with implantable drug delivery devices for cancer pain. Appl Neurophysiol 1985;48:234–241.

    CAS  PubMed  Google Scholar 

  83. Lazorthes YR, Sallerin BAM, and Verdié JCP. Intracerebroventricular administration of morphine for control of irreduci-ble cancer pain. Neurosurgery 1995;37:422–429.

    Article  CAS  PubMed  Google Scholar 

  84. Dennis GC and DeWitty RL. Long-term intraventricular infusion of morphine for intractable pain in cancer of the head and neck. Neurosurgery 1990;26:404–407.

    Article  CAS  PubMed  Google Scholar 

  85. Karavelis A, Foroglou G, Selviaridis P, and Fountzilas G. Intraventricular administration of morphine for control of intractable cancer pain in 90 patients. Neurosurgery 1996;39:57–61.

    Article  CAS  PubMed  Google Scholar 

  86. Baskin DS, Browning JL, Pirozzolo FJ et al. Brain choline acetyltransferase and mental function in Alzheimer disease. Arch Neurol 1999;56:1121–1123.

    Article  CAS  PubMed  Google Scholar 

  87. Passini MA, Watson DJ, Vite CH et al. Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brain of ß-glucuronidase-deficient mice. J Virol 2003;77:7034–7040.

    Article  CAS  PubMed  Google Scholar 

  88. Dohura K, Ishikawa K, Murakami-Kubo I et al. Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models. J Virol 2004;78:4999–5006.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, North Shore LIJ Health System, Manhasset, NY, USA

    Shawn Belverud, Alon Mogilner & Michael Schulder

Authors
  1. Shawn Belverud
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alon Mogilner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Schulder
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Jain PharmaBiotech, Blaesiring 7, Basel, 4057, Switzerland

    Kewal K. Jain

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press, a part of Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Belverud, S., Mogilner, A., Schulder, M. (2010). Intrathecal Drug Delivery by Implanted Pumps. In: Jain, K. (eds) Drug Delivery to the Central Nervous System. Neuromethods, vol 45. Humana Press. https://doi.org/10.1007/978-1-60761-529-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-529-3_6

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-528-6

  • Online ISBN: 978-1-60761-529-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation